Find therapies in clinical trials near you – page 105

Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Phase 1 Safety and Tolerability of Oral VENT-02 in Healthy Volunteers for Neuroinflammatory and Neurodegenerative Diseases

Phase 1b Study of CC-90010 with Temozolomide in Adults with Newly Diagnosed Glioblastoma After Surgery

Phase 1b Study of CC-90010 with Temozolomide in Adults with Newly Diagnosed Glioblastoma After Surgery

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Safety, Tolerability and Pharmacokinetics of Zosurabalpin After Multiple Intravenous Doses in Healthy Participants

Study of alogabat oral 60 mg capsule and IV 100 µg microdose in healthy male participants to assess mass balance, absolute bioavailability and metabolism

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study